Company research / BIOF

Blue Biofuels, Inc. (BIOF)

SEC name BLUE BIOFUELS, INC. · CIK 0001549145 · OTC · Industrial Organic Chemicals

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

Partial revenue. In this company's filings, net income for the year ended 2019-12-31 is larger than reported revenue. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-312016-12-312015-12-31
Revenuen/an/an/an/an/an/an/a$60.0Kn/an/an/a
Gross Profitn/an/an/an/an/an/an/an/a$134.3Kn/an/a
R&D Expense$2.30M$2.31M$2.33M$1.85M$2.35M$1.10M$763.2K$797.9K$736.8K$698.8Kn/a
Operating Income-$3.51M-$3.72M-$4.06M-$3.19M-$3.93M-$2.17M-$1.99M-$1.78M-$4.91M-$4.30M-$5.33M
Depreciation & Amortization$111.3K$145.9K$118.8K$119.5K$138.5K$131.7K$40.1K$31.4K$85.5K$73.9K$233.8K
EBITDA-$3.40M-$3.57M-$3.94M-$3.07M-$3.79M-$2.04M-$1.95M-$1.75M-$4.83M-$4.23M-$5.10M
Net Income-$3.12M-$2.87M-$1.42M-$3.06M-$3.96M-$2.14M-$2.18M$1.01M-$10.26M-$8.32M-$5.16M
EPS (Diluted)n/a-$0.01-$0.01-$0.01n/an/an/an/an/an/an/a
Total Assets$1.32M$1.41M$1.39M$1.03M$1.11M$1.84M$892.5K$609.6K$4.59M$9.02M$8.82M
Total Liabilities$5.38M$5.11M$4.24M$4.59M$3.46M$3.23M$4.23M$3.94M$3.81M$3.68M$5.13M
Long-Term Debtn/an/an/an/an/an/a$100.0Kn/an/an/a$1.25M
Shareholders' Equity-$4.06M-$3.71M-$2.85M-$3.56M-$2.36M-$1.40M-$3.34M-$3.33M$780.3K$5.34M$4.14M
Cash & Equivalents$22.0K$65.2K$48.8K$41.0K$211.9K$1.16M$286.6K$110.6K$55.1K$49.7K$62.1K
Operating Cash Flow-$1.23M-$845.0K-$1.00M-$1.60M-$2.04M-$2.47M-$921.4K-$1.20M-$1.84M-$2.24M-$2.01M
Capital Expendituresn/a$68.9K$71.1K$287.8K$138.2K$216.4K$147.2Kn/a$8.0K$18.0K$214.2K
Free Cash Flown/a-$913.9K-$1.07M-$1.89M-$2.17M-$2.68M-$1.07Mn/a-$1.85M-$2.26M-$2.23M
Shares Outstanding323.52M317.87M307.96M302.75M289.94M274.00M241.72M219.51M97.54M71.71M41.08M
Weighted Average Diluted Sharesn/a312.19M303.85M299.95Mn/an/an/an/an/an/an/a
EPS (Basic)n/a-$0.01-$0.01-$0.01-$0.01-$0.01-$0.01$0.01n/an/an/a